An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.

An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.

AIMS: To investigate the effect of treatment with pioglitazone on beta-cell function and insulin sensitivity in Type 2 diabetes. METHODS: Thirty subjects with diet-controlled Type 2 diabetes were randomized to 3 months treatment with pioglitazone (n = 19) or placebo (n = 11). All subjects underwent...

Bibliografski detalji
Glavni autori:	Wallace, T, Levy, J, Matthews, DR
Format:	Journal article
Jezik:	English
Izdano:	2004

Slični predmeti

Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.
od: Effie Tozzo, i dr.
Izdano: (2015-01-01)

Pioglitazone and metformin.
od: Hill, N, i dr.
Izdano: (2007)

The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
od: Juan P. Palavicini, i dr.
Izdano: (2021-12-01)

Pioglitazone/metformin - Viewpoint
od: Matthews, DR
Izdano: (2006)

Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.
od: Turner, R, i dr.
Izdano: (1990)

Safety and tolerability of pioglitazone
od: Belcher, G, i dr.
Izdano: (2000)

Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study
od: Hanadi Al Hamad, i dr.
Izdano: (2020-04-01)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
od: Sun Ok Song, i dr.
Izdano: (2012-10-01)

Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes
od: Lin Y, i dr.
Izdano: (2025-03-01)

Pioglitazone/Metformin: A viewpoint by David R. Matthews
od: Matthews, DR
Izdano: (2006)

Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
od: Hsin-Chung Lin, i dr.
Izdano: (2023-04-01)

Pioglitazone improves insulin sensitivity, reduces visceral fat and stimulates lipolysis in non diabetic dialyzed patients
od: Anne Zanchi, i dr.
Izdano: (2012-06-01)

Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes.
od: Yoshinori Watanabe, i dr.
Izdano: (2015-01-01)

Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot study.
od: Anne Zanchi, i dr.
Izdano: (2014-01-01)

Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
od: Toshikazu Yamanouchi
Izdano: (2010-03-01)

The role of pioglitazone in antioxidant, anti-inflammatory, and insulin sensitivity in a high fat-carbohydrate diet-induced rat model of insulin resistance
od: H.M. Al-Muzafar, i dr.
Izdano: (2021-05-01)

Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin.
od: Hao Yin, i dr.
Izdano: (2013-01-01)

The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
od: Matthews, DR, i dr.
Izdano: (1997)

Pulsatile, synchronous basal insulin and glucagon secretion in man.
od: Lang, D, i dr.
Izdano: (1982)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
od: Rachman, J, i dr.
Izdano: (1996)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone ( 2012;36:371-8)
od: Sheyu Li, i dr.
Izdano: (2013-02-01)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone ( 2012;36:371-8)
od: Sang-Yong Kim
Izdano: (2012-12-01)

Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone ( 2012;36:371-8)
od: Kwang Joon Kim, i dr.
Izdano: (2013-02-01)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
od: Stanley S Schwartz
Izdano: (2010-07-01)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
od: Schwartz S
Izdano: (2010-07-01)

Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
od: Levy, J, i dr.
Izdano: (1991)

Insulin resistance and beta-cell function--a clinical perspective.
od: Matthews, DR
Izdano: (2001)

Insulin resistance and beta-cell function - a clinical perspective.
od: Matthews, DR
Izdano: (2001)

Oxidized LDL, insulin sensitivity and beta-cell function in newborns
od: Jun Zhang, i dr.
Izdano: (2021-03-01)

Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings.
od: Lang, D, i dr.
Izdano: (1979)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
od: Sami N. Nasrallah, i dr.
Izdano: (2012-04-01)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
od: Sami N. Nasrallah, i dr.
Izdano: (2012-01-01)

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.
od: Turner, R, i dr.
Izdano: (1976)

Pioglitazone‐induced alterations of purine metabolism in healthy male subjects
od: Jihyun Kang, i dr.
Izdano: (2024-05-01)

Calorie restriction increases insulin sensitivity to promote beta cell homeostasis and longevity in mice
od: Cristiane dos Santos, i dr.
Izdano: (2024-10-01)

The relationship between the insulin resistance syndrome and insulin sensitivity in the first-degree relatives of subjects with non-insulin dependent diabetes mellitus.
od: Shaw, J, i dr.
Izdano: (1998)

HORMONE SIGNALING - BASAL INSULIN-SECRETION AND ACUTE INSULIN-RESPONSE IN NORMAL AND GLUCOSE INTOLERANT MAN
od: Rice, H, i dr.
Izdano: (1993)

Ellagic acid potentiates insulin sensitising activity of pioglitazone in L6 myotubes
od: Rakesh P. Nankar, i dr.
Izdano: (2015-05-01)

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
od: Schernthaner, G, i dr.
Izdano: (2004)

Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man.
od: Lang, D, i dr.
Izdano: (1981)